Skip to navigation | Skip to main content | Skip to footer
Menu
Menu Search the University of Manchester siteSearch
Search type

Alternatively, use our A–Z index

Dr Andrew Clamp - personal details

Contact details

Role: Clinical Senior Lecturer in Medical Oncology

Tel: +44 (0)161 446 3391

Location:


Cancer Research UK Dept of Medical Oncology,

Institute of Cancer Sciences,
The University of Manchester,
Manchester Academic Health Sciences Centre,
The Christie NHS Foundation Trust,
Wilmslow Road,
Manchester,
M20 4BX
 

Websites

 

Biography

I qualified in medicine by gaining a first class honours degree from the University of Cambridge and then subsequently completing my clinical training (BMBCh) at the University of Oxford in 1996. My specialist training in Medical Oncology has taken place in Manchester at the Christie Hospital and I was awarded my Certificate of Completion of Training in 2007.

During my training in Manchester I have gained extensive experience in the design and running of clinical trials, particularly in ovarian cancer. I was also awarded a PhD for work in the laboratory of Professor John Gallagher determining the role of heparan sulphate in determining the bioactivity of collagen- XVIII derived endostatin, a key endogenous anti-angiogenic protein. This research was funded through a Cancer Research UK McElwain Clinical Research Fellowship.

I currently lead the gynaecological cancers clinical research team at The Christie which coordinate a diverse portfolio of phase Ib- III clinical trials nad have recently been appointed Women's Cancer Centre Lead for the University of Manchester.

I am the International Chief Investigator for the ICON8 clinical trials programme which is funded by Cancer Research UK and run in collaboration with the MRC Clinical Trials Unit and NCRI Gynaecological Cancers Clinical Studies Group. This programme is investigating the use of weekly dose-dense chemotherapy scheduling in the first-line management of advanced ovarian cancer and how this integrates with delayed primary surgery and the anti-VEGF monoclonal antibody bevaiczumab. In collaboration with Dr James Brenton (University of Cambridge) we have established a large ICON8 sample biobank for translational research with an initial focus on identifying predictive biomakers of efficacy for weekly dose-dense chemotherapy scheduling. 
 

Memberships of Committees and Professional Bodies

NCRI Gynaceological Cancers Clinical Studies Group

American Society of Clinical Oncology

Association of Cancer Physicians

Qualifications

MA. BMBCh (Oxford), PhD, MRCP (UK)

Role

I am a Clinical Senior Lecturer and Women's Cancer Centre Lead for the Institute of Cancer Sciences, University of Manchester . I also have an Honorary Consultant Appointment in Medical Oncology at The Christie NHS Foundation Trust, Manchester. I sit on the National Cancer Research Institute Gynaecological Cancers Clinical Studies Group and both the ovarian and endometrial subgroups.

Teaching

I teach regularly on the undergraduate medical course at the University of Manchester and as part of the MRes Oncology Programme. I have been invited to give several national/ international teaching lectures including 'Incorporating Anti-vascular therapy into the Management of Ovarian Cancer' at the European Cancer Congress in Amsterdam in October 2013.